The Warburg hypothesis and the emergence of the mitochondrial metabolic theory of cancer.
Level 5 - mechanism / opinion, no new human data
Narrative review and theoretical perspective with no new human data
PubMed 40199815 · doi:10.1007/s10863-025-10059-w
What was done
This narrative review re-evaluates Otto Warburg's hypothesis of oncogenesis—oxidative phosphorylation (OxPhos) insufficiency followed by compensatory fermentation—in the context of modern cancer bioenergetics.
What was found
The abstract reports no numerical data. It presents biochemical arguments that oxygen consumption and extracellular lactate do not accurately quantify ATP synthesis, that glutaminolysis-driven mitochondrial substrate-level phosphorylation provides significant ATP, and that cytoplasmic lipid droplets along with aerobic fermentation mark OxPhos insufficiency.
Why it matters
Clarifying that alternative pathways generate ATP despite impaired OxPhos resolves historical contradictions in the Warburg effect and supports metabolic strategies for cancer management.
Limits
This is a narrative, mechanism-based perspective without new empirical data, clinical trials, or systematic review methodology. Therapeutic claims regarding metabolic cancer management are theoretical and not directly tested here.